Tsuruha Holdings Inc.
FY2026 February Period Q3 Financial Summary [Japan GAAP] (Consolidated)
Consolidated sales for the third quarter of the FY2026 February period amounted to JPY 833,383 million, operating income was JPY 40,595 million, and net income attributable to owners of parent was JPY 26,976 million.
Key Figures
- Sales: 833,383 million yen (FY2026 February Q3)
- Operating Income: 40,595 million yen (FY2026 February Q3)
- Net Income Attributable to Owners of Parent (Quarterly): 26,976 million yen (FY2026 February Q3)
AI要約
Performance Overview
For the consolidated cumulative period of Q3 in FY2026 February period (March 1, 2025 to November 30, 2025), sales were JPY 833,383 million, operating income was JPY 40,595 million, ordinary income was JPY 40,733 million, and net income attributable to owners of parent was JPY 26,976 million. No year-over-year comparison has been made due to the change in fiscal period. The economic environment saw a gradual recovery amid the impact of US trade policies. The drugstore industry has expanded its market size amid intensifying competition and increasing price sensitivity. Our company has been promoting strengthening of prescription and private brands and completed a business integration with Welcia Holdings Co., Ltd. on December 1, 2025.
Financial Position and Store Expansion
Total assets increased by JPY 81,088 million to JPY 664,451 million compared to the previous consolidated fiscal year-end; total liabilities increased by JPY 62,267 million to JPY 339,252 million; and total net assets increased by JPY 18,821 million to JPY 325,198 million. The equity ratio declined by 3.2 points to 45.0%. The number of directly operated stores was 2,690 (up 32 stores from the previous fiscal year-end), with 78 store openings and 46 store closures. Considering the stock split (1 share to 5 shares), earnings per share were JPY 110.73 and net assets per share were JPY 1,225.03.
Outline of Business Integration
As of December 1, 2025, our company completed the business integration by making Welcia Holdings Co., Ltd. a wholly-owned subsidiary through a share exchange. This created the largest drugstore alliance in Japan, strengthening competitiveness, and targeting growth into Asia's No.1 global company. The acquisition cost was JPY 667,784 million; the market value of shares held immediately before the business combination was JPY 10,675 million; and the market value of Tsuruha Holdings’ common stock issued in the share exchange was JPY 657,108 million.
